Sara Bailey bought $1K-$15K of BYRN stock

Sara Bailey, Director, Office of National Drug Control Policy, disclosed a purchase of Byrna Technologies Inc. (BYRN) stock worth $1K-$15K in an OGE Form 278-T released Jun 11, 2026.

The trade happened on Mar 1, 2026, 102 days before it was made public.

BYRN has moved -69.9% since the trade date, from $12.78 to $3.85 (Nov 13, 2026 close).